

share
Adiphenine Hydrochloride CAS NO 50-42-0
Unit Price:
CAS No.:50-42-0
Grade:Pharmacy Grade
Content:99.9%
Brand:Customizable
Packaging:Customizable
Description
Adiphenine Hydrochloride is a pharmaceutical-grade anticholinergic agent, recognized for its role as a smooth muscle relaxant. This compound is critical for formulators requiring a reliable active pharmaceutical ingredient (API) with well-characterized pharmacological activity. It is primarily utilized in the pharmaceutical industry for the development of antispasmodic medications and in related research applications.
Application
- Pharmaceutical API: Core active ingredient in antispasmodic and anticholinergic drug formulations.
- Gastrointestinal Therapeutics: Used in medications to treat conditions like irritable bowel syndrome (IBS) and peptic ulcers by reducing smooth muscle spasms.
- Neurological Research: Serves as a reference standard and tool compound in studies investigating cholinergic receptor mechanisms.
- Veterinary Medicine: Employed in veterinary pharmaceuticals for its muscle relaxant properties in animals.
- Analytical Standard: High-purity material for use in quality control laboratories for HPLC, LC-MS, or NMR analysis.
Basic Information
| Product Name | Adiphenine Hydrochloride |
| CAS No. | 50-42-0 |
| Molecular Formula | C20H25NO2·HCl |
| Molecular Weight | 347.88 g/mol |
| Synonyms | Adiphenine HCl; 2-Diethylaminoethyl 2,2-Diphenylacetate Hydrochloride; Trasentine Hydrochloride; Diphenylacetyl-diethylaminoethanol Hydrochloride; 2-(Diethylamino)ethyl Diphenylacetate Hydrochloride; Diethylaminoethyl Diphenylglycolate Hydrochloride; Spasmolytin; Adiphenin Hydrochloride |
| EINECS | 200-048-4 |
Quality Control
Our Adiphenine Hydrochloride is manufactured under strict quality systems. Each batch is tested to ensure it meets high-purity standards suitable for pharmaceutical applications. A comprehensive Certificate of Analysis (COA) is provided, detailing results for identity, purity, and related substances. We support compliance with major pharmacopoeial standards, including USP and EP, upon request.
Storage
Preserve in a tightly closed container, protected from light. Store in a cool, dry place at controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive) and must be kept in a dry environment to prevent degradation.
Specification
| Item | Specification |
|---|---|
| Appearance | White to off-white crystalline powder |
| Identification (IR) | Conforms to structure |
| Identification (HPLC) | Retention time matches reference standard |
| Assay (HPLC) | 98.0% - 102.0% (on anhydrous basis) |
| Water Content (KF) | ≤ 1.0% |
| Residue on Ignition | ≤ 0.1% |
| Related Substances (HPLC) | Total impurities ≤ 2.0% Any single impurity ≤ 0.5% |
Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.
Hot Related Products


Drotaverine Hydrochloride CAS NO 985-12-6


Propantheline Bromide CAS NO 50-34-0


Hexocyclium Metilsulfate CAS NO 115-63-9


Tridihexethyl Iodide CAS NO 125-99-5


Oxyphencyclimine CAS NO 125-52-0


Oxyphencyclimine CAS NO 125-53-1


Fenpiverinium Bromide CAS NO 125-60-0


Piperidolate Hydrochloride CAS NO 129-77-1


Amprotropine CAS NO 134-53-2


n-(3,4-Dimethoxyphenethyl)-2-(3,4-Dimethoxyphenyl)Acetamide CAS NO 139-76-4


Tiemonium Iodide CAS NO 144-12-7


Spirgetine CAS NO 144-45-6


Scopolamine Butylbromide CAS NO 149-64-4


Alverine CAS NO 150-59-4


Methscopolamine Bromide CAS NO 155-41-9


Trepirium CAS NO 1018-34-4


Benzilonium Bromide CAS NO 1050-48-2


Propenzolate CAS NO 1420-03-7


Bietamiverine CAS NO 1477-10-7


Barverine CAS NO 1639-79-8
Why choose US
Trusted Manufacturer
With our own production facilities, we ensure consistent quality, reliable supply, and full traceability.
Rigorous Quality Assurance
Each batch undergoes strict QC, accompanied by COA, MSDS, and full compliance with international standards.
Advanced R&D Expertise
Our in-house lab drives process innovation, new product development, and tailored synthesis solutions.






